Omkar Pharma Acquisition

Omkar Speciality Chemicals (Thane, India) says it has acquired LASA Laboratory (Raigad, India), the company’s first foray into pharmaceutical ingredients. LASA owns an active pharmaceutical ingredient (API) manufacturing facility and makes products aimed the anthelmintic and veterinary active ingredients markets. Omkar Speciality Chemicals manufactures selenium derivatives, iodine derivatives, molybdenum derivatives, cobalt bismuth derivatives and pharma intermediates. “The acquisition will enable us to focus on manufacturing anthelmintics, such as...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers